Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia-Reference-Cited by-同舟云学术

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Published:2014-02-08 Issue:12 Volume:53 Page:2167-2174
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Fleischmann Roy,Kerr Bradley,Yeh Li-Tain,Suster Matt,Shen Zancong,Polvent Elizabeth,Hingorani Vijay,Quart Barry,Manhard Kimberly,Miner Jeffrey N.,Baumgartner Scott

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/53/12/2167/17388308/ket487.pdf

Reference35 articles.

1. Gout: on the brink of novel therapeutic options for an ancient disease;Bieber;Arthritis Rheum,2004

2. High plasma uric acid concentration: causes and consequences;de Oliveira;Diabetol Metab Syndr,2012

3. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT);Zhang;Ann Rheum Dis,2006

4. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT);Zhang;Ann Rheum Dis,2006

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous determination of lesinurad and febuxostat in commercial fixed-dose combinations using a greener normal-phase HPTLC method;Green Processing and Synthesis;2024-01-01

2. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout;Expert Opinion on Drug Metabolism & Toxicology;2023-11-25

3. MODERN VIEW ON ANTI-INFLAMMATORY AND URAT-LOWERING THERAPY FOR GOUT;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-11-03

4. Agents for the Treatment of Gout: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2023-11-01

5. Dynamic Kinetic Resolution of Indole-Based Sulfenylated Heterobiaryls by Rhodium-Catalyzed Atroposelective Reductive Aldol Reaction;ACS Catalysis;2023-08-30